Salud financiera de hoja de balance de ResMed
Salud financiera controles de criterios 6/6
ResMed tiene un patrimonio de accionistas total de $4.5B y una deuda total de $1.2B, lo que sitúa su ratio deuda-patrimonio en 27.4%. Sus activos y pasivos totales son $6.9B y $2.4B respectivamente. El BAIT de ResMed es de $1.2B, por lo que su ratio de cobertura de intereses es de 19.6. Tiene efectivo e inversiones a corto plazo que ascienden a $217.9M.
Información clave
21.7%
Ratio deuda-patrimonio
US$1.01b
Deuda
| Ratio de cobertura de intereses | 23.6x |
| Efectivo | US$259.45m |
| Patrimonio | US$4.63b |
| Total pasivo | US$2.18b |
| Activos totales | US$6.81b |
Actualizaciones recientes sobre salud financiera
ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30
We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06Recent updates
ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06ResMed: The GARP Story Continues, Technicals Showing Vital Signs
Jan 26Why The 23% Return On Capital At ResMed (NYSE:RMD) Should Have Your Attention
Jan 23We Ran A Stock Scan For Earnings Growth And ResMed (NYSE:RMD) Passed With Ease
Dec 28Calculating The Fair Value Of ResMed Inc. (NYSE:RMD)
Dec 16ResMed: Strong Earnings Growth Supports The High Valuation, Unclear Technical Trends
Nov 14Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($2.4B) de RMD superan a sus pasivos a corto plazo ($764.1M).
Pasivo a largo plazo: Los activos a corto plazo de RMD ($2.4B) superan a sus pasivos a largo plazo ($1.7B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: El ratio deuda neta-patrimonio (22.5%) de RMD se considera satisfactorio.
Reducción de la deuda: El ratio deuda-patrimonio de RMD ha pasado de 61.2% a 27.4% en los últimos 5 años.
Cobertura de la deuda: La deuda de RMD está bien cubierta por el flujo de caja operativo (88%).
Cobertura de intereses: Los pagos de intereses de la deuda de RMD están bien cubiertos por el BAIT (19.6x cobertura).